Coherus Oncology reported a gross margin of 70.35% and a net margin of -144.20% for the quarter ended Jun 2026. These financial ratios cover 52 quarters of results from Sep 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 74.21% | 83.50% | 84.41% | 81.25% | 22.43% | 68.68% | 47.98% | 57.68% | 56.14% | 7.60% | 37.65% | 82.43% | 54.91% | 64.44% | 65.09% | 66.89% | 67.84% | 68.27% | 69.02% | 70.35% | ||||||||||||||||||||||||||||||||
| EBT Margin | -46.70% | -62.34% | -159.83% | -83.37% | -190.76% | -129.81% | -233.47% | -73.01% | -53.67% | -87.03% | -2,947.83% | -532.74% | -786.50% | -596.06% | -623.74% | -437.51% | -384.73% | -363.56% | -300.04% | -233.08% | ||||||||||||||||||||||||||||||||
| EBIT Margin | -39.74% | -53.91% | -134.62% | -73.17% | -177.11% | -113.54% | -208.86% | -58.83% | -42.92% | -75.29% | -2,937.05% | -384.87% | -774.22% | -586.89% | -597.91% | -443.59% | -383.14% | -359.90% | -293.67% | -225.98% | ||||||||||||||||||||||||||||||||
| EBITDA Margin | -39.74% | -53.91% | -134.62% | -73.17% | -177.11% | -113.54% | -208.86% | -58.83% | -42.92% | -75.29% | -2,937.05% | -384.87% | -774.22% | -586.89% | -597.91% | -443.59% | -383.14% | -359.90% | -293.67% | -225.98% | ||||||||||||||||||||||||||||||||
| Operating Margin | -39.74% | -53.91% | -134.62% | -73.17% | -177.11% | -113.54% | -208.86% | -58.83% | -42.92% | -75.29% | -2,937.05% | -384.87% | -774.22% | -586.89% | -597.91% | -443.59% | -383.14% | -359.90% | -293.67% | -225.98% | ||||||||||||||||||||||||||||||||
| Net Margin | -46.70% | -62.34% | -159.83% | -83.37% | -190.76% | -129.81% | -233.47% | -73.01% | -53.16% | -87.03% | 4,457.32% | -125.50% | -177.64% | -655.58% | -744.43% | 2,903.91% | -307.07% | -295.29% | -311.35% | -144.20% | ||||||||||||||||||||||||||||||||
| FCF Margin | 16.30% | -71.97% | -90.93% | -84.65% | -82.66% | -220.59% | -212.37% | -66.45% | -72.82% | -14.17% | 6,111.66% | 968.67% | -1,024.72% | 369.95% | -401.96% | 4,259.49% | -400.48% | -220.36% | -470.24% | -433.98% | ||||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 38.63M | 37.61M | 37.29M | 34.34M | 29.73M | 33.26M | 44.10M | 56.70M | 65.39M | 64.69M | 62.29M | 62.07M | 54.90M | 25.92M | 3.86M | 4.02M | 3.28M | 2.61M | 4.00M | 5.25M | ||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 740.63M | 710.53M | 636.36M | 569.70M | 548.46M | 515.88M | 441.64M | 436.01M | 526.69M | 606.69M | 696.57M | 719.20M | 589.93M | 476.77M | 409.80M | 405.26M | 477.99M | 387.43M | 262.18M | 228.60M | ||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 286.97M | 173.24M | 208.41M | 173.41M | 148.11M | 108.06M | 49.38M | 71.29M | 116.66M | 56.36M | 165.61M | -38.37M | -42.15M | -81.67M | -120.46M | 156.69M | 124.73M | 98.06M | 115.77M | 98.08M | ||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.49 | 0.46 | 0.48 | 0.48 | 0.44 | 0.41 | 0.42 | 0.42 | 0.40 | 0.42 | 0.33 | 0.25 | 0.19 | 0.06 | 0.08 | 0.08 | 0.08 | 0.11 | 0.18 | 0.22 | ||||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -5.68 | -6.83 | -9.02 | -6.69 | -10.67 | -5.49 | -6.98 | -3.47 | -3.12 | -6.49 | -21.74 | -9.76 | -16.57 | -23.74 | -21.13 | -19.98 | -19.07 | -20.40 | -16.54 | -13.92 | ||||||||||||||||||||||||||||||||
| Debt Ratio | 0.21 | 0.11 | 0.33 | 0.36 | 0.45 | 0.51 | 0.61 | 0.52 | 0.43 | 0.40 | 0.32 | 0.07 | 0.09 | 0.11 | 0.17 | 0.08 | 0.07 | 0.14 | 0.14 | 0.19 | ||||||||||||||||||||||||||||||||
| Times Interest Earned | -5.68 | -6.83 | -9.02 | -6.69 | -10.67 | -5.49 | -6.98 | -3.47 | -3.12 | -6.49 | -21.74 | -9.76 | -16.57 | -23.74 | -21.13 | -19.98 | -19.07 | -20.40 | -16.54 | -13.92 | ||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -31.94 | -26.85 | -10.39 | -11.22 | -8.63 | -10.61 | -7.27 | -9.41 | -10.29 | -4.69 | 2.64 | -15.42 | -11.15 | -3.15 | -1.66 | 0.28 | -5.37 | -4.57 | -6.80 | -10.48 | ||||||||||||||||||||||||||||||||
| Price to SalesP/S | 14.92 | 16.74 | 16.61 | 9.35 | 16.45 | 13.77 | 16.97 | 6.87 | 5.47 | 4.08 | 117.53 | 19.36 | 19.80 | 20.63 | 12.35 | 8.27 | 16.47 | 13.50 | 21.17 | 15.12 | ||||||||||||||||||||||||||||||||
| Price to BookP/B | 9.41 | 12.56 | 79.47 | -24.86 | -7.69 | -4.54 | -2.80 | -2.31 | -3.05 | -1.93 | -3.31 | -2.37 | -1.36 | -1.21 | -0.51 | 0.71 | 2.17 | 2.82 | 3.31 | 3.55 | ||||||||||||||||||||||||||||||||
| Enterprise Value | 761.99M | 810.61M | 672.76M | 287.08M | 460.57M | 432.82M | 422.45M | 258.56M | 277.01M | 255.93M | 11.48M | 40.05M | 22.13M | 33.56M | 11.47M | -152.79M | -1.04M | -0.09M | 93.58M | 110.95M | ||||||||||||||||||||||||||||||||
| EV to EBIT | -23.24 | -20.50 | -8.31 | -6.52 | -5.72 | -8.41 | -6.24 | -7.49 | -8.65 | -3.71 | -0.17 | -1.01 | -0.47 | -0.74 | -0.25 | 3.36 | 0.02 | 0.00 | -2.59 | -3.43 | ||||||||||||||||||||||||||||||||
| EV to EBITDA | -23.24 | -20.50 | -8.31 | -6.52 | -5.72 | -8.41 | -6.24 | -7.49 | -8.65 | -3.71 | -0.17 | -1.01 | -0.47 | -0.74 | -0.25 | 3.36 | 0.02 | 0.00 | -2.59 | -3.43 | ||||||||||||||||||||||||||||||||
| Market Capitalization | 1,230.69M | 1,227.80M | 998.44M | 562.57M | 747.38M | 624.50M | 550.54M | 403.27M | 408.08M | 373.68M | 271.26M | 199.29M | 119.82M | 159.55M | 93.88M | 84.84M | 190.63M | 172.04M | 260.63M | 216.26M | ||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | 91.50 | -23.26 | -18.27 | -11.05 | -19.91 | -6.24 | -7.99 | -10.34 | -7.52 | -28.81 | 1.92 | 2.00 | -1.93 | 5.58 | -3.07 | 0.19 | -4.11 | -6.12 | -4.50 | -3.48 | ||||||||||||||||||||||||||||||||
| EV to FCF | 56.65 | -15.36 | -12.31 | -5.64 | -12.27 | -4.33 | -6.13 | -6.63 | -5.10 | -19.73 | 0.08 | 0.40 | -0.36 | 1.17 | -0.38 | -0.35 | 0.02 | 0.00 | -1.62 | -1.79 | ||||||||||||||||||||||||||||||||
| EV to CFO | 55.57 | -15.49 | -12.45 | -5.74 | -12.42 | -4.33 | -6.15 | -6.64 | -5.10 | -19.78 | -0.25 | 0.67 | -0.36 | 1.17 | -0.44 | 3.28 | 0.02 | 0.00 | -1.62 | -1.79 | ||||||||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -39.74% | -53.91% | -134.62% | -73.17% | -177.11% | -113.54% | -208.86% | -58.83% | -42.92% | -75.29% | -2,937.05% | -384.87% | -774.22% | -586.89% | -597.91% | -443.59% | -383.14% | -359.90% | -293.67% | -225.98% | ||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -49.46% | -48.40% | -36.76% | -45.99% | -64.95% | -68.10% | -76.58% | -87.87% | -64.73% | -73.91% | -128.41% | -81.31% | -75.82% | -103.03% | -114.57% | -129.32% | -170.91% | -73.32% | -132.34% | -103.66% | ||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | -69.77% | -197.36% | -234.52% | |||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -31.28% | -40.41% | -33.04% | -40.46% | -50.80% | -56.55% | -61.45% | -60.58% | -41.22% | -39.21% | -8.51% | -4.08% | -0.08% | 5.98% | -31.95% | 44.35% | 32.42% | 43.37% | 71.04% | -57.80% |